On the public citation graph
Milan criteria in liver transplantation for hepatocellular carcinoma: An evidence-based analysis of 15 years of experience
0 signed · 698 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
1 of the 114 references listed on this page is in the Retraction Watch database as retracted (export 2026-11-04): 10.1097/tp.0b013e31816b67e4 (notice 2019-08-01).
Dataset join, best-effort; this page does not check the publisher record. Retraction Watch data via Crossref Labs, used with credit; OpenCitations Index (CC0) and Meta (CC BY 4.0); dataset doi:10.7910/DVN/WT8VOA (CC BY 4.0).
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/archsurg.140.4.353openalex-snapshot
Twenty-Year Experience With Liver Transplantation for Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1002/hep.22412openalex-snapshot
Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: An intention-to-treat analysis
inferredcites →https://doi.org/10.1002/hep.22693openalex-snapshot
Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the scientific registry of transplant recipients database†‡
inferredcites →https://doi.org/10.1002/hep.23260openalex-snapshot
Use of Sorafenib in Patients With Hepatocellular Carcinoma Before Liver Transplantation: A Cost-Benefit Analysis While Awaiting Data on Sorafenib Safety
inferredcites →https://doi.org/10.1002/hep.23332openalex-snapshot
Multifaceted Perspective of the Waiting List for Liver Transplantation: the Value of Pharmacokinetic Models
inferredcites →https://doi.org/10.1002/hep.23439openalex-snapshot
Hepatocellular Carcinoma: Sorafenib Before Liver Transplantation?
inferredcites →https://doi.org/10.1002/hep.23702openalex-snapshot
Sorafenib Therapy in Patients with Hepatocellular Carcinoma Before Liver Transplantation†
inferredcites →https://doi.org/10.1002/hep.510250629openalex-snapshot
Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: A comparative study
inferredcites →https://doi.org/10.1002/hep.510270616openalex-snapshot
Liver transplantation for small hepatocellular carcinoma: The tumor-node-metastasis classification does not have prognostic power
inferredcites →https://doi.org/10.1002/jso.21415openalex-snapshot
Liver transplantation versus liver resection for the treatment of hepatocellular carcinoma
inferredcites →https://doi.org/10.1002/lt.20039openalex-snapshot
Underestimation of the influence of satellite nodules as a risk factor for post-transplantation recurrence in patients with small hepatocellular carcinoma
inferredcites →https://doi.org/10.1002/lt.20128openalex-snapshot
Recurrence of hepatocellular carcinoma after liver transplant: Patterns and prognosis
inferredcites →https://doi.org/10.1002/lt.20140openalex-snapshot
Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome
inferredcites →https://doi.org/10.1002/lt.20237openalex-snapshot
Sirolimus-based immunosuppression for liver transplantation in the presence of extended criteria for hepatocellular carcinoma
inferredcites →https://doi.org/10.1002/lt.20239openalex-snapshot
Liver transplantation for hepatocellular carcinoma: Further considerations on selection criteria
inferredcites →https://doi.org/10.1002/lt.20311openalex-snapshot
Liver transplantation outcomes for early-stage hepatocellular carcinoma: Results of a multicenter study
inferredcites →https://doi.org/10.1002/lt.20677openalex-snapshot
Living donor liver transplantation for hepatocellular carcinoma: A single-center preliminary report
inferredcites →https://doi.org/10.1002/lt.20837openalex-snapshot
Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma
inferredcites →https://doi.org/10.1002/lt.20847openalex-snapshot
Optimizing Staging for Hepatocellular Carcinoma Before Liver Transplantation: A Retrospective Analysis of the Unos/Optn Database
inferredcites →https://doi.org/10.1002/lt.20884openalex-snapshot
Impact of UCSF criteria according to pre- and post-OLT tumor features: Analysis of 479 patients listed for HCC with a short waiting time
inferredcites →https://doi.org/10.1002/lt.20936openalex-snapshot
Transplantation for hepatocellular carcinoma: The Milan criteria and beyond
inferredcites →https://doi.org/10.1002/lt.21033openalex-snapshot
Response to Preoperative Chemoembolization Correlates with Outcome After Liver Transplantation in Patients with Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1002/lt.21078openalex-snapshot
Recurrent Hepatocellular Carcinoma After Transplantation
inferredcites →https://doi.org/10.1002/lt.21368openalex-snapshot
Liver transplantation in patients with hepatocellular carcinoma across Milan criteria
inferredcites →https://doi.org/10.1002/lt.21399openalex-snapshot
Outcome of Patients With Hepatocellular Carcinoma Listed for Liver Transplantation Within the Eurotransplant Allocation System
inferredcites →https://doi.org/10.1002/lt.21671openalex-snapshot
Addition of adult-to-adult living donation to liver transplant programs improves survival but at an increased cost
inferredcites →https://doi.org/10.1002/lt.21778openalex-snapshot
An intention-to-treat analysis of liver transplantation for hepatocellular carcinoma using organ procurement transplant network data
inferredcites →https://doi.org/10.1002/lt.21940openalex-snapshot
Living Donor Liver Transplantation for Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1002/lt.21993openalex-snapshot
Tumor recurrence following liver transplantation for hepatocellular carcinoma: Role of tumor proliferation status
inferredcites →https://doi.org/10.1002/lt.21999openalex-snapshot
Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States
inferredcites →https://doi.org/10.1002/lt.22039openalex-snapshot
Prediction of progression-free survival in patients presenting with hepatocellular carcinoma within the Milan criteria
inferredcites →https://doi.org/10.1007/bf02557525openalex-snapshot
Comparison of hepatic resection and hepatic transplantation in the treatment of hepatocellular carcinoma among cirrhotic patients
inferredcites →https://doi.org/10.1007/pl00009946openalex-snapshot
Liver transplantation in the treatment of hepatocellular carcinoma
inferredcites →https://doi.org/10.1007/pl00009947openalex-snapshot
Pattern and management of recurrent hepatocellular carcinoma after liver transplantation
inferredcites →https://doi.org/10.1007/s00268-001-0214-1openalex-snapshot
Liver Transplantation for Malignant Diseases: Selection andPattern of Recurrence
inferredcites →https://doi.org/10.1007/s00432-010-0802-2openalex-snapshot
Surgical treatment for early hepatocellular carcinoma: comparison of resection and liver transplantation
inferredcites →https://doi.org/10.1007/s00534-005-1018-8openalex-snapshot
The role of living-donor liver transplantation in surgical treatment for hepatocellular carcinoma
inferredcites →https://doi.org/10.1007/s00534-005-1079-8openalex-snapshot
Living-donor liver transplantation for hepatocellular carcinoma
inferredcites →https://doi.org/10.1007/s10620-008-0604-4openalex-snapshot
Liver Transplantation, Liver Resection, and Transarterial Chemoembolization for Hepatocellular Carcinoma in Cirrhosis: Which Is the Best Oncological Approach?
inferredcites →https://doi.org/10.1007/s10654-010-9491-zopenalex-snapshot
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
inferredcites →https://doi.org/10.1016/j.ejso.2005.06.003openalex-snapshot
Tumour size is an important predictor for the outcome after liver transplantation for hepatocellular carcinoma
inferredcites →https://doi.org/10.1016/j.ejso.2007.07.208openalex-snapshot
Liver transplantation for hepatocellular carcinoma: Are the Milan criteria still valid?
inferredcites →https://doi.org/10.1016/j.idc.2010.07.004openalex-snapshot
Epidemiology and Management of Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1016/j.jamcollsurg.2007.05.023openalex-snapshot
Liver Transplantation for Hepatocellular Carcinoma: University Hospital Essen Experience and Metaanalysis of Prognostic Factors
inferredcites →https://doi.org/10.1016/j.jamcollsurg.2010.01.007openalex-snapshot
Liver Transplantation for Hepatocellular Carcinoma in the Model for End-Stage Liver Disease Era
inferredcites →https://doi.org/10.1016/j.jhep.2010.12.040openalex-snapshot
The impact of waiting list alpha-fetoprotein changes on the outcome of liver transplant for hepatocellular carcinoma
inferredcites →https://doi.org/10.1016/j.lts.2003.09.012openalex-snapshot
Midterm cost-effectiveness of the liver transplantation program of England and Wales for three disease groups
inferredcites →https://doi.org/10.1016/j.transproceed.2003.08.018openalex-snapshot
Survival after liver transplantation for hepatocellular carcinoma
inferredcites →https://doi.org/10.1016/j.transproceed.2003.10.076openalex-snapshot
Hepatocellular carcinoma in liver transplant era: a clinicopathologic analysis
inferredcites →https://doi.org/10.1016/j.transproceed.2004.08.098openalex-snapshot
Liver transplantation for patients with hepatocellular carcinoma
inferredcites →https://doi.org/10.1016/j.transproceed.2004.08.144openalex-snapshot
Can we expand the Milan criteria for hepatocellular carcinoma in living donor liver transplantation?
inferredcites →https://doi.org/10.1016/j.transproceed.2005.02.059openalex-snapshot
Liver Transplant Results for Hepatocellular Carcinoma Applying Strict Preoperative Selection Criteria
inferredcites →https://doi.org/10.1016/j.transproceed.2005.03.143openalex-snapshot
Liver Transplantation for Hepatocellular Carcinoma in Cirrhosis: Prognostic Parameters
inferredcites →https://doi.org/10.1016/j.transproceed.2005.06.031openalex-snapshot
Predictive Factors of Outcome After Liver Transplantation in Patients With Cirrhosis and Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1016/j.transproceed.2007.05.031openalex-snapshot
Long-Term Results of Liver Transplantation for Hepatocellular Carcinoma: An Update of the University of Padova Experience
inferredcites →https://doi.org/10.1016/j.transproceed.2007.05.083openalex-snapshot
Outcome After Liver Transplantation in Patients With Cirrhosis and Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1016/j.transproceed.2007.06.059openalex-snapshot
Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma: Recurrence Pathway and Prognostic Factors
inferredcites →https://doi.org/10.1016/j.transproceed.2008.03.175openalex-snapshot
Salvage Liver Transplantation for Recurrent Hepatocellular Carcinoma After Liver Resection: Feasibility of the Milan Criteria and Operative Risk
inferredcites →https://doi.org/10.1016/j.transproceed.2009.01.104openalex-snapshot
Orthotopic Liver Transplantation for Hepatocellular Carcinoma: One Center's Experience in the Northeast of Brazil
inferredcites →https://doi.org/10.1016/j.transproceed.2009.02.023openalex-snapshot
Milan Criteria Versus San Francisco Criteria in Hepatocellular Carcinoma: Our Center's Experience
inferredcites →https://doi.org/10.1016/j.transproceed.2009.02.028openalex-snapshot
Liver Transplantation for Hepatocellular Carcinoma: Results of a Multicenter Study With Common Priorization Criteria
inferredcites →https://doi.org/10.1016/j.transproceed.2009.03.058openalex-snapshot
Liver Transplantation for Hepatitis B Virus–Related Hepatocellular Carcinoma: One Center's Experience in China
inferredcites →https://doi.org/10.1016/j.transproceed.2009.08.016openalex-snapshot
Impact of Tumor Characteristic on the Outcome of Liver Transplantation in Patients With Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1016/j.transproceed.2009.11.034openalex-snapshot
Liver Transplantation Results for Hepatocellular Carcinoma in Chile
inferredcites →https://doi.org/10.1016/j.transproceed.2010.01.045openalex-snapshot
Treatment of Hepatocellular Carcinoma With Liver Transplantation: A Single-Center Experience From Brazil
inferredcites →https://doi.org/10.1016/j.transproceed.2010.02.014openalex-snapshot
Management of Hepatocellular Carcinoma Recurrence After Liver Transplantation
inferredcites →https://doi.org/10.1016/s0168-8278(97)80462-xopenalex-snapshot
Liver resection of transplantation for hepatocellular carcinoma?
inferredcites →https://doi.org/10.1016/s0739-5930(09)79363-8openalex-snapshot
Reassessing Selection Criteria Prior to Liver Transplantation for Hepatocellular Carcinoma Utilizing the Scientific Registry of Transplant Recipients Database
inferredcites →https://doi.org/10.1016/s1072-7515(03)00140-6openalex-snapshot
Surgical Treatment of Hepatocellular Cancer in the Era of Hepatic Transplantation
inferredcites →https://doi.org/10.1016/s1470-2045(08)70284-5openalex-snapshot
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
inferredcites →https://doi.org/10.1034/j.1399-0012.1999.130615.xopenalex-snapshot
An active liver transplant programme for hepatocellular carcinoma in cirrhotic patients: is it justified?
inferredcites →https://doi.org/10.1053/j.gastro.2004.09.042openalex-snapshot
Living donor liver transplantation for hepatocellular carcinoma
inferredcites →https://doi.org/10.1053/jhep.2001.23561openalex-snapshot
Vascular Invasion and Histopathologic Grading Determine Outcome After Liver Transplantation for Hepatocellular Carcinoma in Cirrhosis
inferredcites →https://doi.org/10.1053/jhep.2001.24563openalex-snapshot
Liver Transplantation for Hepatocellular Carcinoma: Expansion of the Tumor Size Limits Does Not Adversely Impact Survival
inferredcites →https://doi.org/10.1053/jlts.2002.34892openalex-snapshot
Liver transplantation for hepatocellular carcinoma: Comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria
inferredcites →https://doi.org/10.1055/s-2005-871198openalex-snapshot
Resection and Liver Transplantation for Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1056/nejm199603143341104openalex-snapshot
Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis
inferredcites →https://doi.org/10.1093/ije/dym018openalex-snapshot
Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography
inferredcites →https://doi.org/10.1097/00000658-199308000-00005openalex-snapshot
Liver Resection Versus Transplantation for Hepatocellular Carcinoma in Cirrhotic Patients
inferredcites →https://doi.org/10.1097/00000658-199803000-00015openalex-snapshot
Survival and Recurrence After Liver Transplantation Versus Liver Resection for Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1097/00000658-200105000-00009openalex-snapshot
Liver Transplantation for Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1097/00007890-200212270-00017openalex-snapshot
Low recurrence rate of hepatocellular carcinoma after liver transplantation: better patient selection or lower immunosuppression?
inferredcites →https://doi.org/10.1097/01.sla.0000137129.98894.42openalex-snapshot
Living Donor Liver Transplantation for Adult Patients With Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1097/01.sla.0000225255.01668.65openalex-snapshot
Difference in Tumor Invasiveness in Cirrhotic Patients With Hepatocellular Carcinoma Fulfilling the Milan Criteria Treated by Resection and Transplantation
inferredcites →https://doi.org/10.1097/01.tp.0000047029.02806.16openalex-snapshot
Living-donor liver transplantation for hepatocellular carcinoma
inferredcites →https://doi.org/10.1097/01.tp.0000226069.66819.7eopenalex-snapshot
Accuracy of Staging as a Predictor for Recurrence After Liver Transplantation for Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1097/sla.0b013e318148c704openalex-snapshot
Liver Transplantation Criteria For Hepatocellular Carcinoma Should Be Expanded
inferredcites →https://doi.org/10.1097/tp.0b013e3181622ff8openalex-snapshot
Living Donor Liver Transplantation for Hepatocellular Carcinoma: A Single-Center Experience in Taiwan
inferredcites →https://doi.org/10.1097/tp.0b013e31816b67e4openalex-snapshot
Liver Transplantation for Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1097/tp.0b013e3181814de2openalex-snapshot
The Timing of Liver Transplantation After Primary Hepatectomy for Hepatocellular Carcinoma: A Special Reference to Recurrence Pattern and Milan Criteria
inferredcites →https://doi.org/10.1097/tp.0b013e3181cd4ae9openalex-snapshot
Prospective Study on the Outcome of Patients With Hepatocellular Carcinoma Registered for Living Donor Liver Transplantation: How Long Can They Wait?
inferredcites →https://doi.org/10.1111/j.1399-3046.2009.01062.xopenalex-snapshot
Liver transplantation in children with hepatocellular carcinoma Do Milan criteria apply to pediatric patients?
inferredcites →https://doi.org/10.1111/j.1432-2277.2004.00046.xopenalex-snapshot
Liver transplantation in hepatocellular carcinoma
inferredcites →https://doi.org/10.1111/j.1432-2277.2006.00338.xopenalex-snapshot
Impact of incidentally found hepatocellular carcinoma on the outcome of living donor liver transplantation
inferredcites →https://doi.org/10.1111/j.1432-2277.2007.00505.xopenalex-snapshot
Predictors of long-term outcome following liver transplantation for hepatocellular carcinoma: a single-center experience
inferredcites →https://doi.org/10.1111/j.1432-2277.2007.00597.xopenalex-snapshot
Superiority of transplantation versus resection for the treatment of small hepatocellular carcinoma
inferredcites →https://doi.org/10.1111/j.1432-2277.2010.01111.xopenalex-snapshot
The challenges of liver transplantation for hepatocellular carcinoma on cirrhosis
inferredcites →https://doi.org/10.1111/j.1572-0241.2005.00289.xopenalex-snapshot
Predictors of Long-Term Survival After Liver Transplantation for Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1111/j.1600-6143.2006.01719.xopenalex-snapshot
Intention-to-Treat Analysis of Liver Transplantation in Selected, Aggressively Treated HCC Patients Exceeding the Milan Criteria
inferredcites →https://doi.org/10.1111/j.1600-6143.2007.01965.xopenalex-snapshot
Liver Transplantation for Hepatocellular Carcinoma: Validation of the UCSF‐Expanded Criteria Based on Preoperative Imaging
inferredcites →https://doi.org/10.1111/j.1600-6143.2008.02229.xopenalex-snapshot
Liver Transplantation for Recurrent Hepatocellular Carcinoma on Cirrhosis After Liver Resection: University of Bologna Experience
inferredcites →https://doi.org/10.1111/j.1600-6143.2008.02351.xopenalex-snapshot
Liver Transplantation for Hepatocellular Carcinoma: Beyond the Milan Criteria
inferredcites →https://doi.org/10.1111/j.1600-6143.2008.02409.xopenalex-snapshot
Liver Transplantation for Hepatocellular Carcinoma: Results of Down-Staging in Patients Initially Outside the Milan Selection Criteria
inferredcites →https://doi.org/10.1111/j.1600-6143.2010.03127.xopenalex-snapshot
Hepatocellular Carcinoma Patients Are Advantaged in the Current Liver Transplant Allocation System
inferredcites →https://doi.org/10.1159/000078741openalex-snapshot
Liver Transplantation in Cirrhotic Patients with Small Hepatocellular Carcinoma: An Analysis of Pre-Operative Imaging, Explant Histology and Prognostic Histologic Indicators
inferredcites →https://doi.org/10.1159/000106911openalex-snapshot
HCC in Living Donor Liver Transplantation: Can We Expand the Milan Criteria?
inferredcites →https://doi.org/10.1200/jco.1999.17.1.324openalex-snapshot
Recurrence Patterns of Hepatocellular and Fibrolamellar Carcinoma After Liver Transplantation
inferredcites →https://doi.org/10.1200/jco.2003.11.137openalex-snapshot
The Outcome of Liver Transplantation in Patients With Hepatocellular Carcinoma in the United States Between 1988 and 2001: 5-Year Survival Has Improved Significantly With Time
inferredcites →https://doi.org/10.1245/s10434-007-9559-5openalex-snapshot
Liver Transplantation for Hepatocellular Carcinoma
inferredcites →https://doi.org/10.3310/hta7270openalex-snapshot
Evaluating non-randomised intervention studies
inferredcites →https://doi.org/10.3748/wjg.15.4170openalex-snapshot
Indicators of prognosis after liver transplantation in Chinese hepatocellular carcinoma patients
inferredcites →https://doi.org/10.4321/s1130-01082006001200002openalex-snapshot
Survival of patients receiving a liver transplant for hepatocellular carcinoma, and risk of tumor recurrence
inferredcites →https://doi.org/10.7326/acpjc-2001-134-1-a15openalex-snapshot
Evidence-Based Medicine: How to Practice and Teach EBM
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1001/jamaoncol.2026.3901openalex-snapshot
Immune Checkpoint Inhibitor–Based Downstaging Therapy for Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1001/jamasurg.2022.7989openalex-snapshot
Management of Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1002/14651858.cd013346openalex-snapshot
Abdominal ultrasound and alpha-fetoprotein for the diagnosis of hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/14651858.cd013346.pub2openalex-snapshot
Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease
inferred← citeshttps://doi.org/10.1002/14651858.cd013362openalex-snapshot
Computed tomography for the diagnosis of hepatocellular carcinoma in chronic advanced liver disease
inferred← citeshttps://doi.org/10.1002/14651858.cd013362.pub2openalex-snapshot
Computed tomography for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease
inferred← citeshttps://doi.org/10.1002/14651858.cd013483openalex-snapshot
Contrast-enhanced ultrasound for the diagnosis of hepatocellular carcinoma in advanced chronic liver disease
inferred← citeshttps://doi.org/10.1002/14651858.cd013483.pub2openalex-snapshot
Contrast-enhanced ultrasound for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease
inferred← citeshttps://doi.org/10.1002/14651858.cd014798openalex-snapshot
Magnetic resonance imaging for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease
inferred← citeshttps://doi.org/10.1002/14651858.cd014798.pub2openalex-snapshot
Magnetic resonance imaging for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease
inferred← citeshttps://doi.org/10.1002/bjs.10196openalex-snapshot
Long-term survival of patients undergoing liver resection for very large hepatocellular carcinomas
inferred← citeshttps://doi.org/10.1002/cld.499openalex-snapshot
Criteria for liver transplantation in hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/cld.773openalex-snapshot
Looking for the Best Model to Predict Hepatocellular Carcinoma Recurrence After Liver Transplantation in Latin America
inferred← citeshttps://doi.org/10.1002/cld.839openalex-snapshot
Latinoamérica: en busca del mejor modelo predictivo de recurrencia del hepatocarcinoma después del trasplante
inferred← citeshttps://doi.org/10.1002/deo2.225openalex-snapshot
Fully covered metallic stents for anastomotic biliary strictures after living donor liver transplantation
inferred← citeshttps://doi.org/10.1002/hep.27191openalex-snapshot
Evaluation of the Pediatric Patient for Liver Transplantation: 2014 Practice Guideline by the American Association for the Study of Liver Diseases, American Society of Transplantation and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition
inferred← citeshttps://doi.org/10.1002/hep.28420openalex-snapshot
Squaring the circle of selection and allocation in liver transplantation for HCC: An adaptive approach
inferred← citeshttps://doi.org/10.1002/hep.30278openalex-snapshot
Is It Time to Reconsider the Milan Criteria for Selecting Patients With Hepatocellular Carcinoma for Deceased‐Donor Liver Transplantation?
inferred← citeshttps://doi.org/10.1002/hep.31318openalex-snapshot
Liver Transplantation Following Yttrium‐90 Radioembolization: 15‐Year Experience in 207‐Patient Cohort
inferred← citeshttps://doi.org/10.1002/hep.32613openalex-snapshot
Hepatocellular carcinoma downstaging for liver transplantation in the era of systemic combined therapy with anti‐VEGF/TKI and immunotherapy
inferred← citeshttps://doi.org/10.1002/hep4.1564openalex-snapshot
Hepatocellular Carcinoma Survival by Etiology: A SEER‐Medicare Database Analysis
inferred← citeshttps://doi.org/10.1002/hep4.1644openalex-snapshot
Predictors of Outcomes of Patients Referred to a Transplant Center for Urgent Liver Transplantation Evaluation
inferred← citeshttps://doi.org/10.1002/jcsm.13053openalex-snapshot
Impact of muscle mass on survival of patients with hepatocellular carcinoma after liver transplantation beyond the Milan criteria
inferred← citeshttps://doi.org/10.1002/jmri.27065openalex-snapshot
Interreader Agreement of Liver Imaging Reporting and Data System on MRI: A Systematic Review and Meta‐Analysis
inferred← citeshttps://doi.org/10.1002/jso.23531openalex-snapshot
Transplant versus resection for the management of hepatocellular carcinoma meeting Milan Criteria in the MELD exception era at a single institution in a UNOS region with short wait times
inferred← citeshttps://doi.org/10.1002/jso.23673openalex-snapshot
Hepatocellular carcinoma: A comprehensive overview of surgical therapy
inferred← citeshttps://doi.org/10.1002/jso.23739openalex-snapshot
Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with peritoneal hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/jso.24500openalex-snapshot
Outcomes of patients with hepatocellular carcinoma are determined in multidisciplinary team meetings
inferred← citeshttps://doi.org/10.1002/lt.22350openalex-snapshot
2010 International consensus conference on liver transplantation for hepatocellular carcinoma: Texts of experts
inferred← citeshttps://doi.org/10.1002/lt.22470openalex-snapshot
Meeting Report of the 2011 Joint International Congress of the International Liver Transplantation Society, the European Liver and Intestine Transplant Association, and the Liver Intensive Care Group of Europe
inferred← citeshttps://doi.org/10.1002/lt.23706openalex-snapshot
Alpha-fetoprotein and modified response evaluation criteria in Solid Tumors progression after locoregional therapy as predictors of hepatocellular cancer recurrence and death after transplantation
inferred← citeshttps://doi.org/10.1002/lt.23846openalex-snapshot
Bland embolization versus chemoembolization of hepatocellular carcinoma before transplantation
inferred← citeshttps://doi.org/10.1002/lt.23897openalex-snapshot
Combined hepatocellular-cholangiocarcinoma: A population-level analysis of an uncommon primary liver tumor
inferred← citeshttps://doi.org/10.1002/lt.24615openalex-snapshot
Correlation of tumor response on computed tomography with pathological necrosis in hepatocellular carcinoma treated by chemoembolization before liver transplantation
inferred← citeshttps://doi.org/10.1002/lt.24758openalex-snapshot
Liver transplantation versus liver resection for hepatocellular carcinoma in intention to treat: An attempt to perform an ideal meta‐analysis
inferred← citeshttps://doi.org/10.1002/lt.24977openalex-snapshot
Pilot study of living donor liver transplantation for patients with hepatocellular carcinoma exceeding Milan Criteria (Barcelona Clinic Liver Cancer extended criteria)
inferred← citeshttps://doi.org/10.1002/lt.25191openalex-snapshot
Antitumor effect of sorafenib and mammalian target of rapamycin inhibitor in liver transplantation recipients with hepatocellular carcinoma recurrence
inferred← citeshttps://doi.org/10.1002/mp.16140openalex-snapshot
Applicability of multidimensional convolutional neural networks on automated detection of diverse focal liver lesions in multiphase CT images
inferred← citeshttps://doi.org/10.1007/978-1-4614-8363-2_13openalex-snapshot
Stereotactic Body Radiation Therapy
inferred← citeshttps://doi.org/10.1007/978-1-4939-1423-4_15openalex-snapshot
Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1007/978-1-4939-2947-4_1openalex-snapshot
Overview: Disease Recurrence After Liver Transplantation
inferred← citeshttps://doi.org/10.1007/978-1-4939-2947-4_11openalex-snapshot
Recurrence of Hepatocellular Carcinoma Following Liver Transplantation Within Milan Criteria
inferred← citeshttps://doi.org/10.1007/978-3-030-24490-3_13openalex-snapshot
The Management of Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1007/978-3-030-26226-6_5openalex-snapshot
Prognostic Implications of Physical Frailty and Sarcopenia Pre and Post Transplantation
inferred← citeshttps://doi.org/10.1007/978-3-030-37482-2_5-1openalex-snapshot
IR Liver-Directed Therapies for HCC
inferred← citeshttps://doi.org/10.1007/978-3-030-41683-6_5openalex-snapshot
IR Liver-Directed Therapies for HCC
inferred← citeshttps://doi.org/10.1007/978-3-030-47963-3_24openalex-snapshot
Hepatopancreaticobiliary Surgery in the Elderly
inferred← citeshttps://doi.org/10.1007/978-3-031-52546-9_38openalex-snapshot
Transarterial Chemoembolization
inferred← citeshttps://doi.org/10.1007/978-3-032-03935-4_23openalex-snapshot
Hepatocellular Carcinoma: Staging and Clinical Management
inferred← citeshttps://doi.org/10.1007/978-3-319-05543-5_11-1openalex-snapshot
Liver Transplantation for HCC: The Milan Criteria
inferred← citeshttps://doi.org/10.1007/978-3-319-05543-5_11-2openalex-snapshot
Liver Transplantation for HCC: The Milan Criteria
inferred← citeshttps://doi.org/10.1007/978-3-319-05543-5_23-1openalex-snapshot
Interventional Radiology for the Pre-Transplant Patient
inferred← citeshttps://doi.org/10.1007/978-3-319-05543-5_23-2openalex-snapshot
Interventional Radiology for the Pre-Transplant Patient
inferred← citeshttps://doi.org/10.1007/978-3-319-07209-8_11openalex-snapshot
Liver Transplantation for HCC: The Milan Criteria
inferred← citeshttps://doi.org/10.1007/978-3-319-07209-8_23openalex-snapshot
Interventional Radiology for the Pre-transplant Patient
inferred← citeshttps://doi.org/10.1007/978-3-319-26779-1_99-1openalex-snapshot
Electrochemotherapy of Primary Liver Tumors
inferred← citeshttps://doi.org/10.1007/978-3-319-30103-7_36openalex-snapshot
Liver Transplantation: An Overview
inferred← citeshttps://doi.org/10.1007/978-3-319-32886-7_99openalex-snapshot
Electrochemotherapy of Primary Liver Tumors
inferred← citeshttps://doi.org/10.1007/978-3-319-34214-6_27openalex-snapshot
Clinical Features and Clinician’s Diagnostic Approach to Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1007/978-3-319-34214-6_32openalex-snapshot
Liver Transplantation for Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1007/978-3-319-54531-8_13openalex-snapshot
Hepatocellular Carcinoma: Epidemiology, Basic Principles of Treatment, and Clinical Data
inferred← citeshttps://doi.org/10.1007/978-3-319-60861-7_23openalex-snapshot
Benign and Malignant Lesions of the Liver
inferred← citeshttps://doi.org/10.1007/978-3-319-71300-7_34openalex-snapshot
Transarterial Chemoembolization
inferred← citeshttps://doi.org/10.1007/978-3-319-91977-5_1openalex-snapshot
Patient Selection and Technical Considerations
inferred← citeshttps://doi.org/10.1007/978-3-642-13327-5_192openalex-snapshot
Liver PET/CT and Molecular Imaging
inferred← citeshttps://doi.org/10.1007/978-94-007-7675-3_34openalex-snapshot
Serum Alpha-Fetoprotein as a Biomarker in Liver Transplantation
inferred← citeshttps://doi.org/10.1007/978-94-007-7742-2_34-1openalex-snapshot
Serum Alpha-Fetoprotein as a Biomarker in Liver Transplantation
inferred← citeshttps://doi.org/10.1007/978-981-10-2010-0_10openalex-snapshot
Advances in Gastrointestinal Surgery
inferred← citeshttps://doi.org/10.1007/978-981-13-0161-2_8openalex-snapshot
Advances in Gastrointestinal Surgery
inferred← citeshttps://doi.org/10.1007/978-981-19-0063-1_18openalex-snapshot
Use of Radiotherapy Alone and in Combination with Other Therapies for Hepatocellular Carcinoma: Rationale and Future Directions
inferred← citeshttps://doi.org/10.1007/978-981-95-2624-6_11openalex-snapshot
Liver Transplantation for Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1007/s00108-025-01960-yopenalex-snapshot
Malignome und Transplantation
inferred← citeshttps://doi.org/10.1007/s00259-023-06155-xopenalex-snapshot
[177Lu]Lu-PSMA-617 theranostic probe for hepatocellular carcinoma imaging and therapy
inferred← citeshttps://doi.org/10.1007/s00261-014-0180-3openalex-snapshot
Multiparametric Gd-EOB-DTPA magnetic resonance in diagnosis of HCC: dynamic study, hepatobiliary phase, and diffusion-weighted imaging compared to histology after orthotopic liver transplantation
inferred← citeshttps://doi.org/10.1007/s00261-017-1217-1openalex-snapshot
Liver transplantation for hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1007/s00261-017-1360-8openalex-snapshot
Contrast-enhanced ultrasound of malignant liver lesions
inferred← citeshttps://doi.org/10.1007/s00261-019-02311-wopenalex-snapshot
LI-RADS and transplantation: challenges and controversies
inferred← citeshttps://doi.org/10.1007/s00261-020-02704-2openalex-snapshot
The role of interventional radiology in the pre-liver transplant patient
inferred← citeshttps://doi.org/10.1007/s00261-021-03069-wopenalex-snapshot
Therapies for hepatocellular carcinoma: overview, clinical indications, and comparative outcome evaluation—part one: curative intention
inferred← citeshttps://doi.org/10.1007/s00261-023-03819-yopenalex-snapshot
Single-center analysis of percutaneous ablation in the treatment of hepatocellular carcinoma: long-term outcomes of a 7-year experience
inferred← citeshttps://doi.org/10.1007/s00261-025-04811-4openalex-snapshot
Association of LR treatment response category with outcome of patients with hepatocellular carcinoma on explant pathology
inferred← citeshttps://doi.org/10.1007/s00330-019-06424-0openalex-snapshot
Gadoxetic acid–enhanced MRI as a predictor of recurrence of HCC after liver transplantation
inferred← citeshttps://doi.org/10.1007/s00330-023-09950-0openalex-snapshot
Hepatobiliary-phase gadolinium ethoxybenzyl-diethylenetriaminepentaacetic acid MRI for pretreatment prediction of efficacy-to-standard-therapies based on Barcelona Clinic Liver Cancer algorithm: an up-to-date review
inferred← citeshttps://doi.org/10.1007/s00330-025-11352-3openalex-snapshot
Prognostic and diagnostic value of [18F]FDG, 11C-acetate, and [68Ga]Ga-FAPI-04 PET/CT for hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1007/s00330-026-12920-xopenalex-snapshot
Preoperative radioembolization versus chemoembolization and upfront resection for resectable hepatocellular carcinoma beyond the Milan criteria
inferred← citeshttps://doi.org/10.1007/s00423-012-0911-2openalex-snapshot
HCC: current surgical treatment concepts
inferred← citeshttps://doi.org/10.1007/s00423-012-1029-2openalex-snapshot
Could radiofrequency ablation replace liver resection for small hepatocellular carcinoma in patients with compensated cirrhosis? A 5-year follow-up
inferred← citeshttps://doi.org/10.1007/s00423-017-1582-9openalex-snapshot
Treatment and outcomes of recurrent hepatocellular carcinomas
inferred← citeshttps://doi.org/10.1007/s00423-023-03144-4openalex-snapshot
Global liver transplantation: emerging trends and ethical challenges
inferred← citeshttps://doi.org/10.1007/s00464-019-07357-xopenalex-snapshot
Minimally invasive surgery versus radiofrequency ablation for single subcapsular hepatocellular carcinoma ≤ 2 cm with compensated liver cirrhosis
inferred← citeshttps://doi.org/10.1007/s00464-021-08456-4openalex-snapshot
Optimal drainage of anastomosis stricture after living donor liver transplantation
inferred← citeshttps://doi.org/10.1007/s00595-013-0792-1openalex-snapshot
High risk of lung metastasis after resection of hepatocellular carcinoma more than 7 cm in diameter
inferred← citeshttps://doi.org/10.1007/s00726-013-1662-2openalex-snapshot
Glycine inhibits angiogenic signaling in human hepatocellular carcinoma cells
inferred← citeshttps://doi.org/10.1007/s10147-026-03091-2openalex-snapshot
The immunological paradox: immune checkpoint inhibitors in liver transplantation
inferred← citeshttps://doi.org/10.1007/s10353-017-0487-8openalex-snapshot
Multimodality locoregional treatment strategies for bridging HCC patients before liver transplantation
inferred← citeshttps://doi.org/10.1007/s10620-014-3266-4openalex-snapshot
Intent-to-Treat Analysis of Liver Transplant for Hepatocellular Carcinoma in the MELD Era: Impact of Hepatitis C and Advanced Status
inferred← citeshttps://doi.org/10.1007/s10620-015-3541-zopenalex-snapshot
Extended Ischemia Times Promote Risk of HCC Recurrence in Liver Transplant Patients
inferred← citeshttps://doi.org/10.1007/s10620-019-05538-1openalex-snapshot
Assessing Competing Risks for Death Following Liver Transplantation for Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1007/s10620-020-06201-wopenalex-snapshot
Favorable Survival with Non-curative Treatments for Patients with Early-Stage Hepatocellular Carcinoma After Liver Transplant Denial
inferred← citeshttps://doi.org/10.1007/s11033-020-05271-3openalex-snapshot
DNA methylation of SOCS1/2/3 predicts hepatocellular carcinoma recurrence after liver transplantation
inferred← citeshttps://doi.org/10.1007/s11605-018-3688-yopenalex-snapshot
Utility of Tumor Burden Score to Stratify Prognosis of Patients with Hepatocellular Cancer: Results of 4759 Cases from ITA.LI.CA Study Group
inferred← citeshttps://doi.org/10.1007/s11605-022-05559-8openalex-snapshot
Yttrium-90 Radioembolization: Current Indications and Outcomes
inferred← citeshttps://doi.org/10.1007/s11901-012-0151-5openalex-snapshot
Screening and Management of Hepatocellular Carcinoma: The Australian Perspective
inferred← citeshttps://doi.org/10.1007/s11901-012-0156-0openalex-snapshot
Hepatocellular Carcinoma: When to Transplant Outside of Milan Criteria
inferred← citeshttps://doi.org/10.1007/s11901-016-0292-zopenalex-snapshot
HCC: Where Does HCV Therapy Play a Role?
inferred← citeshttps://doi.org/10.1007/s11901-017-0330-5openalex-snapshot
Changes in Liver Transplant Criteria for Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1007/s11901-019-00492-yopenalex-snapshot
Downstaging and Expanded Criteria Hepatocellular Carcinoma Liver Transplantation
inferred← citeshttps://doi.org/10.1007/s11901-024-00641-yopenalex-snapshot
Indication of Liver Transplant for HCC: Current Status and Future Directions
inferred← citeshttps://doi.org/10.1007/s11901-024-00666-3openalex-snapshot
The Role of Laparoscopic Surgery in the Management of Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1007/s11938-015-0049-8openalex-snapshot
Therapeutic Strategies for Hepatocellular Carcinoma: New Advances and Challenges
inferred← citeshttps://doi.org/10.1007/s11938-017-0133-3openalex-snapshot
Hepatocellular Carcinoma and Liver Transplantation: Changing Patterns and Practices
inferred← citeshttps://doi.org/10.1007/s12029-017-9967-0openalex-snapshot
Hepatocellular Cancer: Is Recurrence Inevitable?
inferred← citeshttps://doi.org/10.1007/s12072-023-10515-yopenalex-snapshot
Endoscopic band ligation is safe despite low platelet count and high INR
inferred← citeshttps://doi.org/10.1007/s12149-022-01796-8openalex-snapshot
Metabolic tumor volume predicts long-term survival after transplantation for unresectable colorectal liver metastases: 15 years of experience from the SECA study
inferred← citeshttps://doi.org/10.1007/s12247-026-10418-zopenalex-snapshot
Development of Betulin and Gefitinib-Loaded Lactoferrin Decorated Liposomes against Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1007/s12262-011-0387-2openalex-snapshot
Liver Transplantation for HCC: A Review
inferred← citeshttps://doi.org/10.1007/s12664-017-0732-xopenalex-snapshot
Hepatocellular carcinoma biology predicts survival outcome after liver transplantation in the USA
inferred← citeshttps://doi.org/10.1007/s13277-015-4243-zopenalex-snapshot
The role of liver transplantation or resection for patients with early hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1007/s15004-024-0813-9openalex-snapshot
Stadienabhängige Therapie beim HCC
inferred← citeshttps://doi.org/10.1007/s40273-019-00839-9openalex-snapshot
Economic Implications of Hepatocellular Carcinoma Surveillance and Treatment: A Guide for Clinicians
inferred← citeshttps://doi.org/10.1007/s40336-016-0172-0openalex-snapshot
The role of 90Y-radioembolization in downstaging primary and secondary hepatic malignancies: a systematic review
inferred← citeshttps://doi.org/10.1007/s40472-014-0028-3openalex-snapshot
Liver Transplantation for Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1016/b978-0-12-398523-1.00020-3openalex-snapshot
Current Status of Liver Transplantation
inferred← citeshttps://doi.org/10.1016/b978-0-323-24098-7.00049-6openalex-snapshot
Hepatobiliary Cancer
inferred← citeshttps://doi.org/10.1016/b978-0-323-37591-7.00046-xopenalex-snapshot
Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1016/b978-0-323-99136-0.00017-9openalex-snapshot
Artificial intelligence in liver transplantation
inferred← citeshttps://doi.org/10.1016/b978-0-7020-4762-6.00101-6openalex-snapshot
Liver transplantation
inferred← citeshttps://doi.org/10.1016/b978-1-4557-5117-4.00084-2openalex-snapshot
Interventional Radiology of the Liver
inferred← citeshttps://doi.org/10.1016/b978-84-9113-949-2.00097-4openalex-snapshot
10.1016/b978-84-9113-949-2.00097-4
inferred← citeshttps://doi.org/10.1016/j.acra.2024.01.015openalex-snapshot
Transarterial Chemoembolization Combined with Lenvatinib Plus Sequential Microwave Ablation for Large Hepatocellular Carcinoma Beyond Up-to-Seven Criteria: A Retrospective Cohort Study
inferred← citeshttps://doi.org/10.1016/j.ajg.2022.04.001openalex-snapshot
The diagnostic utility of microRNA 222-3p, microRNA 21-5p, and microRNA 122-5p for HCV-related hepatocellular carcinoma and its relation to direct-acting antiviral therapy
inferred← citeshttps://doi.org/10.1016/j.ajme.2014.05.004openalex-snapshot
Serum clusterin as a marker for diagnosing hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1016/j.amsu.2014.06.006openalex-snapshot
How grim is hepatocellular carcinoma?
inferred← citeshttps://doi.org/10.1016/j.aohep.2020.06.003openalex-snapshot
Argentinian clinical practice guideline for surveillance, diagnosis, staging and treatment of hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1016/j.aohep.2020.100294openalex-snapshot
Impact of Brazilian expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a multicenter study
inferred← citeshttps://doi.org/10.1016/j.asjsur.2018.01.001openalex-snapshot
Fibrosis score impacts survival following resection for hepatocellular carcinoma (HCC): A Surveillance, End Results and Epidemiology (SEER) database analysis
inferred← citeshttps://doi.org/10.1016/j.bcp.2022.115373openalex-snapshot
State of the art and perspectives in pediatric hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1016/j.bpg.2014.08.001openalex-snapshot
Current challenges in liver transplantation for hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1016/j.brachy.2019.01.014openalex-snapshot
125I seed implantation for hepatocellular carcinoma with portal vein tumor thrombus: A systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/j.cgh.2020.08.065openalex-snapshot
A Novel Blood-Based Panel of Methylated DNA and Protein Markers for Detection of Early-Stage Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1016/j.cld.2014.09.002openalex-snapshot
Evaluation and Management of Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1016/j.cld.2015.01.007openalex-snapshot
Surgical Resection and Liver Transplantation for Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1016/j.cld.2020.08.011openalex-snapshot
Expanding Donor Selection and Recipient Indications for Living Donor Liver Transplantation
inferred← citeshttps://doi.org/10.1016/j.cld.2024.12.003openalex-snapshot
Role of Liver Transplant in Primary and Secondary Liver Malignancies
inferred← citeshttps://doi.org/10.1016/j.clinre.2013.11.002openalex-snapshot
RETRACTED: Histological differentiation predicts post-liver transplantation survival time
inferred← citeshttps://doi.org/10.1016/j.clinre.2019.11.006openalex-snapshot
Survival according to recurrence patterns after resection for transplantable hepatocellular carcinoma in HBV endemic area: Appraisal of liver transplantation strategy
inferred← citeshttps://doi.org/10.1016/j.clinre.2020.101590openalex-snapshot
Hepatocellular carcinoma: French Intergroup Clinical Practice Guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, AFEF, SIAD, SFR/FRI)
inferred← citeshttps://doi.org/10.1016/j.clinre.2021.101774openalex-snapshot
Non-invasive diagnosis and follow-up in liver transplantation
inferred← citeshttps://doi.org/10.1016/j.dld.2023.10.029openalex-snapshot
Multidisciplinary Treatment of Hepatocellular Carcinoma in 2023: Italian practice Treatment Guidelines of the Italian Association for the Study of the Liver (AISF), Italian Association of Medical Oncology (AIOM), Italian Association of Hepato-Bilio-Pancreatic Surgery (AICEP), Italian Association…
inferred← citeshttps://doi.org/10.1016/j.ejca.2011.12.021openalex-snapshot
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1016/j.ejso.2015.05.023openalex-snapshot
Optimizing the management of patients with BCLC stage-B hepatocellular carcinoma: Modern surgical resection as a feasible alternative to transarterial chemoemolization
inferred← citeshttps://doi.org/10.1016/j.ejso.2020.09.001openalex-snapshot
Post hepatectomy liver failure (PHLF) – Recent advances in prevention and clinical management
inferred← citeshttps://doi.org/10.1016/j.ejso.2022.08.036openalex-snapshot
A novel multimodal deep learning model for preoperative prediction of microvascular invasion and outcome in hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1016/j.ejso.2024.108366openalex-snapshot
Technique efficacy and complications after ablation as first surgical intervention for hepatocellular carcinoma: A nationwide database study
inferred← citeshttps://doi.org/10.1016/j.gassur.2024.02.029openalex-snapshot
Contemporary trends and outcomes after liver transplantation and resection for intrahepatic cholangiocarcinoma
inferred← citeshttps://doi.org/10.1016/j.hbpd.2019.05.006openalex-snapshot
Hepatocellular carcinoma recurrence after acute liver allograft rejection treatment: A multicenter European experience
inferred← citeshttps://doi.org/10.1016/j.hbpd.2019.06.010openalex-snapshot
Clinical practice guidelines on liver transplantation for hepatocellular carcinoma in China (2018 edition)
inferred← citeshttps://doi.org/10.1016/j.hbpd.2019.09.011openalex-snapshot
Immune checkpoint inhibitor for hepatocellular carcinoma recurrence after liver transplantation
inferred← citeshttps://doi.org/10.1016/j.hbpd.2020.06.011openalex-snapshot
Hangzhou criteria as downstaging criteria in hepatocellular carcinoma before liver transplantation: A multicenter study from China
inferred← citeshttps://doi.org/10.1016/j.heliyon.2026.e45555openalex-snapshot
Genomic alterations in hepatocellular carcinoma patients undergoing liver transplantation predict recurrence and prognosis
inferred← citeshttps://doi.org/10.1016/j.hoc.2026.05.011openalex-snapshot
Liver Transplantation for Liver and Perihilar Neoplasms
inferred← citeshttps://doi.org/10.1016/j.hpb.2015.12.003openalex-snapshot
Systematic review and meta-analysis of outcomes after liver resection in patients with hepatocellular carcinoma (HCC) with and without bile duct thrombus
inferred← citeshttps://doi.org/10.1016/j.hpb.2017.08.004openalex-snapshot
Living donor liver transplantation for hepatocellular carcinoma: results of prospective patient selection by Kyushu University Criteria in 7 years
inferred← citeshttps://doi.org/10.1016/j.hpb.2018.03.002openalex-snapshot
Vascular invasion and survival after liver transplantation for hepatocellular carcinoma: a study from the European Liver Transplant Registry
inferred← citeshttps://doi.org/10.1016/j.hpb.2019.12.011openalex-snapshot
Treatment of hepatocellular carcinoma beyond the Milan criteria. A weighted comparative study of surgical resection versus chemoembolization
inferred← citeshttps://doi.org/10.1016/j.hpb.2023.06.004openalex-snapshot
Survival benefit of second line therapies for recurrent hepatocellular carcinoma: repeated hepatectomy, thermoablation and second-line transplant referral in a real life national scenario
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2016.02.027openalex-snapshot
Randomized Clinical Trial Comparing Proton Beam Radiation Therapy with Transarterial Chemoembolization for Hepatocellular Carcinoma: Results of an Interim Analysis
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2019.12.004openalex-snapshot
Curative Irradiation Treatment of Hepatocellular Carcinoma: A Multicenter Phase 2 Trial
inferred← citeshttps://doi.org/10.1016/j.jacr.2022.09.005openalex-snapshot
ACR Appropriateness Criteria® Management of Liver Cancer: 2022 Update
inferred← citeshttps://doi.org/10.1016/j.jamcollsurg.2016.12.020openalex-snapshot
Liver Transplantation for Advanced Hepatocellular Carcinoma after Downstaging Without Up-Front Stage Restrictions
inferred← citeshttps://doi.org/10.1016/j.jamcollsurg.2017.02.006openalex-snapshot
Liver Transplantation for Malignant Primary Pediatric Hepatic Tumors
inferred← citeshttps://doi.org/10.1016/j.jamcollsurg.2017.09.003openalex-snapshot
Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma Using Quantitative Image Analysis
inferred← citeshttps://doi.org/10.1016/j.jceh.2014.01.002openalex-snapshot
Role of Liver Transplantation for Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1016/j.jceh.2014.04.003openalex-snapshot
The Indian National Association for Study of the Liver (INASL) Consensus on Prevention, Diagnosis and Management of Hepatocellular Carcinoma in India: The Puri Recommendations
inferred← citeshttps://doi.org/10.1016/j.jceh.2024.102401openalex-snapshot
Liver Resection for Hepatocellular Carcinoma: Recent Advances
inferred← citeshttps://doi.org/10.1016/j.jceh.2025.102539openalex-snapshot
Indian National Association for the Study of Liver (INASL) Guidance Statements for Determining Futility in Liver Transplantation
inferred← citeshttps://doi.org/10.1016/j.jfma.2025.06.024openalex-snapshot
Comparison of dosimetry models to predict outcome for radioembolization in patients with intermediate to advanced hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1016/j.jhep.2011.12.001openalex-snapshot
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1016/j.jhep.2012.05.001openalex-snapshot
Liver transplantation for hepatocellular carcinoma in non-cirrhotic livers regardless of the number and size of tumours?
inferred← citeshttps://doi.org/10.1016/j.jhep.2013.02.026openalex-snapshot
Comparative efficacy of sorafenib versus best supportive care in recurrent hepatocellular carcinoma after liver transplantation: A case-control study
inferred← citeshttps://doi.org/10.1016/j.jhep.2018.03.019openalex-snapshot
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1016/j.jhep.2026.07.020openalex-snapshot
Liver transplantation for primary liver cancers in the era of transplant oncology
inferred← citeshttps://doi.org/10.1016/j.jhepr.2022.100578openalex-snapshot
What to do about hepatocellular carcinoma: Recommendations for health authorities from the International Liver Cancer Association
inferred← citeshttps://doi.org/10.1016/j.jhepr.2026.101732openalex-snapshot
HCC recurrence in liver transplants treated with hypothermic oxygenated machine perfusion: An international matched cohort study
inferred← citeshttps://doi.org/10.1016/j.jss.2015.07.033openalex-snapshot
Is radiofrequency ablation applicable for recurrent hepatocellular carcinoma after liver transplantation?
inferred← citeshttps://doi.org/10.1016/j.jvir.2015.08.032openalex-snapshot
Effectiveness of Transarterial Embolization of Hepatocellular Carcinoma as a Bridge to Transplantation
inferred← citeshttps://doi.org/10.1016/j.jvir.2017.11.027openalex-snapshot
Progression of Treated versus Untreated Liver Imaging Reporting and Data System Category 4 Masses after Transcatheter Arterial Embolization Therapy
inferred← citeshttps://doi.org/10.1016/j.mcna.2013.09.003openalex-snapshot
Hepatocellular Carcinoma and Other Liver Lesions
inferred← citeshttps://doi.org/10.1016/j.medcle.2017.08.024openalex-snapshot
Hepatocellular carcinoma: Present and future
inferred← citeshttps://doi.org/10.1016/j.medcli.2017.08.010openalex-snapshot
Carcinoma hepatocelular: presente y futuro
inferred← citeshttps://doi.org/10.1016/j.rgmx.2013.06.028openalex-snapshot
Trasplante hepático clínico
inferred← citeshttps://doi.org/10.1016/j.rgmx.2014.09.004openalex-snapshot
Consenso mexicano de diagnóstico y manejo del carcinoma hepatocelular
showing the first 200 of 584 · page through all 584
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.